Pratik Patel, MD
Urology · Gilbert, AZNPI 1891761169
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (39.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 50 manufacturers reported payments, led by Palette Life Sciences, Inc. at 53.7% of the total. Reporting peaked in 2023 at $21,785 and has fallen 76.2% since, to $5,182 in 2025. Among urology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 418 payments — averaging $138.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Palette Life Sciences, Inc.$31K
- Intuitive Surgical$9K
- Dendreon Pharmaceuticals LLC$6K
- Teleflex LLC$2K
- Profound Medical Corp.$745
- AbbVie$739
- plus $8K from 44 others
Across 1 payment — averaging $12,925 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Teleflex LLC$13K
What the payments were for
- Consulting fees$22,80039%
- Speaking & faculty fees$1,6603%
- Travel & lodging$14,55825%
- Food & beverage$12,50322%
- Education$6,06010%
- Gifts$2170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Solesta$11,816
- Da Vinci Surgical System$8,203
- PROVENGE$5,505
- UroLift System$1,660
- Tulsa-Pro$426
- Barrigel$410
- AquaBeam Robotic System$395
- Nanoknife$303
- ILLUCCIX$284
- Deflux$211
- AQUABEAM SYSTEM$138
- CT3000 Pro Base Unit$133
- UroCuff-DC Disposable, Single$133
- iTIND System$123
- ANKTIVA$117
- Optilume BPH Drug Coated Balloon Catheter$117
- UroLift$109
- INTERSTIM$104
How this compares
$57,799 in reported general payments places this provider in the 95th percentile of 269 urology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 16 | $260,980 |
| MyrbetriqMirabegron | 49 | $46,020 |
| GemtesaVibegron | 20 | $20,871 |
| Tamsulosin Hcl | 502 | $8,356 |
| Finasteride | 233 | $3,367 |
| Bethanechol Chloride | 15 | $1,798 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 54 | $1,467 |
| Silodosin | 12 | $1,031 |
| Solifenacin Succinate | 20 | $939 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 41 | $612 |
| Ciprofloxacin Hcl | 174 | $606 |
| Oxybutynin Chloride ErOxybutynin Chloride | 23 | $424 |
| Bicalutamide | 20 | $284 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $241 |
| Terazosin Hcl | 11 | $185 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi, Myrbetriq | $558 | $307,00065 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $123 | $20,87120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 269 urology providers in Arizona.
Other urology in Gilbert
- Chinedu MmejeGilbert$114K
- John LinGilbert$108K
- Kian AhmadiehGilbert$19K
- Frank SimonciniGilbert$11K
- Devin PatelGilbert$11K
- Mitchell HumphreysPhoenix$358K
- Shawn BlickGoodyear$336K
- Daniel JaffeePhoenix$280K
- Rahul MehanMesa$277K
- Mitzi BarmatzTucson$135K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.